Clinical Outcomes and Risk Factors in COVID-19 Patients

The clinical trajectory of COVID-19 ranges from asymptomatic infection to critical illness characterised by respiratory failure, multiorgan dysfunction and death. Hospitalised cohorts worldwide have demonstrated that older age, male sex and underlying comorbidities—particularly cardiovascular disease, diabetes and chronic kidney disease—consistently increase the risk of intensive care unit (ICU) admission and mortality. Common complications include acute respiratory distress syndrome (ARDS), thromboembolic events and secondary bacterial pneumonia. Biomarkers such as elevated C-reactive protein, D-dimer and lactate dehydrogenase correlate with disease severity and prolonged hospital length of stay. Across successive pandemic waves, shifts in demographic profiles, viral variants and treatment protocols have modified outcomes: for example, younger populations have predominated in later waves with lower case–fatality rates but persistently high resource requirements for those with severe disease. In resource-limited and displaced settings, delayed diagnosis and suboptimal vaccination coverage compound vulnerability. Understanding the interplay between patient-level risk factors and health-system capacity is essential for optimising triage, therapeutic interventions and public-health planning both during COVID-19 and future respiratory pandemics.

Research from Nature Portfolio

A large multicentre cohort spanning six successive waves of infection in northern Iran has provided granular insight into demographic and clinical trends over a two-year period. Among more than 24 000 hospital admissions, in-hospital mortality declined markedly from nearly 23 per cent in the first wave to under 3 per cent in the fifth wave, reflecting evolving patient age profiles, variant virulence and therapeutic advances. Older patients and those with chronic comorbidities remained disproportionately represented among non-survivors. The study further characterised median lengths of stay—five days for survivors versus seven days for non-survivors—and documented shifting patterns in ICU admissions, emphasising the dynamic nature of pandemic-driven healthcare demands.

Clinical Outcomes and Risk Factors in COVID-19 Patients publication trend

The graph below shows the total number of articles in clinical outcomes and risk factors in covid-19 patients across all publications each year (not limited to Nature Index journals).

Technical terms

Comorbidity: Presence of one or more additional medical conditions co-occurring with a primary diagnosis.

Intensive care unit (ICU): Hospital area providing round-the-clock critical care for life-threatening conditions.

Cohort study: Observational research design following a group of individuals over time to assess associations between exposures and outcomes.

Hazard ratio: Measure in survival analysis indicating the relative risk of an event occurring in one group compared with another over a specified period.

References

1. Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study. Scientific Reports (2023).
2. A survival analysis of COVID-19 in the Mexican population. BMC Public Health (2020).
3. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infectious Diseases (2020).
4. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLOS ONE (2020).